Ketamine: Key Predictor of Treatment Response for MDD Identified - Medscape

Submitted by Anonymous (not verified) on Thu, 04/12/2018 - 16:30

MedscapeKetamine: Key Predictor of Treatment Response for MDD IdentifiedMedscapeWASHINGTON — More intense dissociative symptoms exhibited during ketamine infusion for severe depression, particularly depersonalization, may be key predictors of treatment response. In addition, new safety and efficacy data for off-label use of the ...